USPTO serial 87056036
FACTOR THERAPEUTICS
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- KUYKENDALL, LYNDSEY
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FACTOR THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Brisbane QLD 4001, AU
Brisbane QLD 4001, AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erin Morgan Klug
ERIN MORGAN KLUG VARNUM LLP39500 HIGH POINTE BLVDNOVI, MI 48375UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biochemical and chemical preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; protein arrays for medical uses, namely, for the treatment of chronic wounds, ulcers, burns and surgical wounds; biological, pharmaceutical and veterinary preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; biological, pharmaceutical and veterinary preparations for topical administration for treating wounds; biological, pharmaceutical and veterinary preparations for skin care, namely, for treating skin wounds; medical dressings, wound care and healing components, namely, topical compositions for the treatment of wounds; biological, pharmaceutical and veterinary preparations for the treatment of chronic wounds, ulcers, burns and surgical wounds; biological, pharmaceutical and veterinary preparations for the treatment of dermatological diseases and conditions; biological, pharmaceutical and veterinary preparations treatment of ophthalmic diseases, conditions and wounds; synthetic fusion proteins for medical uses; synthetic fusion proteins for wound care, wound healing, treatment of dermatological diseases and treatment of ophthalmic diseases | ABANDONED | — |
| 042 | Medical research; biotechnology research; pharmaceutical research; research in the field of protein arrays for treating chronic wounds, ulcers, burns and surgical wounds; research relating to wound care, skin care and wound healing | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2018 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Nov 30, 2018 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 23, 2018 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jul 9, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 12, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 12, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 7, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 7, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 7, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 25, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 18, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 18, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 18, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2016 | NWAP | NEW APPLICATION ENTERED | — |